Calcineurin Is Required for Pseudohyphal Growth, Virulence, and Drug Resistance in Candida lusitaniae

Candida lusitaniae is an emerging fungal pathogen that infects immunocompromised patients including HIV/AIDS, cancer, and neonatal pediatric patients. Though less prevalent than other Candida species, C. lusitaniae is unique in its ability to develop resistance to amphotericin B. We investigated the role of the calcium-activated protein phosphatase calcineurin in several virulence attributes of C. lusitaniae including pseudohyphal growth, serum survival, and growth at 37°C. We found that calcineurin and Crz1, a C. albicans Crz1 homolog acting as a downstream target of calcineurin, are required for C. lusitaniae pseudohyphal growth, a process for which the underlying mechanism remains largely unknown in C. lusitaniae but hyphal growth is fundamental to C. albicans virulence. We demonstrate that calcineurin is required for cell wall integrity, ER stress response, optimal growth in serum, virulence in a murine systemic infection model, and antifungal drug tolerance in C. lusitaniae. To further examine the potential of targeting the calcineurin signaling cascade for antifungal drug development, we examined the activity of a calcineurin inhibitor FK506 in combination with caspofungin against echinocandin resistant C. lusitaniae clinical isolates. Broth microdilution and drug disk diffusion assays demonstrate that FK506 has synergistic fungicidal activity with caspofungin against echinocandin resistant isolates. Our findings reveal that pseudohyphal growth is controlled by the calcineurin signaling cascade, and highlight the potential use of calcineurin inhibitors and caspofungin for emerging drug-resistant C. lusitaniae infections.

[1]  Jay H. Konieczka,et al.  Convergent Evolution of Calcineurin Pathway Roles in Thermotolerance and Virulence in Candida glabrata , 2012, G3: Genes | Genomes | Genetics.

[2]  J. Heitman,et al.  Comparative analysis of calcineurin signaling between Candida dubliniensis and Candida albicans , 2012, Communicative & integrative biology.

[3]  N. Huynh,et al.  Ocular Involvement in Hospitalized Patients with Candidemia: Analysis at a Boston Tertiary Care Center , 2011, Ocular immunology and inflammation.

[4]  D. Palazzi,et al.  Candida Non-albicans Versus Candida Albicans Fungemia in the Non-neonatal Pediatric Population , 2011, The Pediatric infectious disease journal.

[5]  J. Heitman,et al.  Calcineurin Controls Drug Tolerance, Hyphal Growth, and Virulence in Candida dubliniensis , 2011, Eukaryotic Cell.

[6]  F. Dromer,et al.  Development of Echinocandin Resistance in Clavispora lusitaniae during Caspofungin Treatment , 2011, Journal of Clinical Microbiology.

[7]  J. Heitman,et al.  On the Roles of Calcineurin in Fungal Growth and Pathogenesis , 2010 .

[8]  J. Heitman,et al.  Mechanistic Plasticity of Sexual Reproduction and Meiosis in the Candida Pathogenic Species Complex , 2009, Current Biology.

[9]  Manuel A. S. Santos,et al.  Evolution of pathogenicity and sexual reproduction in eight Candida genomes , 2009, Nature.

[10]  J. Pemán,et al.  Trends in antifungal susceptibility testing using CLSI reference and commercial methods , 2009, Expert review of anti-infective therapy.

[11]  Yong-Hwan Lee,et al.  Functional analysis of MCNA, a gene encoding a catalytic subunit of calcineurin, in the rice blast fungus magnaporthe oryzae. , 2009, Journal of microbiology and biotechnology.

[12]  F. Chapeland-leclerc,et al.  Role of Sho1p adaptor in the pseudohyphal development, drugs sensitivity, osmotolerance and oxidant stress adaptation in the opportunistic yeast Candida lusitaniae , 2008, Yeast.

[13]  B. Da Silva,et al.  Insight into the Role of HOG Pathway Components Ssk2p, Pbs2p, and Hog1p in the Opportunistic Yeast Candida lusitaniae , 2008, Eukaryotic Cell.

[14]  D. Kontoyiannis,et al.  Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. , 2008, Medical mycology.

[15]  F. Chapeland-leclerc,et al.  Contributions of the Response Regulators Ssk1p and Skn7p in the Pseudohyphal Development, Stress Adaptation, and Drug Sensitivity of the Opportunistic Yeast Candida lusitaniae , 2008, Eukaryotic Cell.

[16]  G. Cole,et al.  Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans. , 2007, Fungal genetics and biology : FG & B.

[17]  F. Chapeland-leclerc,et al.  Differential Involvement of Histidine Kinase Receptors in Pseudohyphal Development, Stress Adaptation, and Drug Sensitivity of the Opportunistic Yeast Candida lusitaniae , 2007, Eukaryotic Cell.

[18]  J. Heitman,et al.  Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections , 2007, Nature Reviews Microbiology.

[19]  N. Gow,et al.  Hyphal Orientation of Candida albicans Is Regulated by a Calcium-Dependent Mechanism , 2007, Current Biology.

[20]  K. Wilhelmus,et al.  Genetically regulated filamentation contributes to Candida albicans virulence during corneal infection. , 2007, Microbial pathogenesis.

[21]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[22]  M. Morris,et al.  Echinocandins in the management of invasive fungal infections, part 1. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[23]  William R. Kirkpatrick,et al.  Calcineurin Controls Growth, Morphology, and Pathogenicity in Aspergillus fumigatus , 2006, Eukaryotic Cell.

[24]  N. Miller,et al.  Phenotypic Switching in Candida lusitaniae on Copper Sulfate Indicator Agar: Association with Amphotericin B Resistance and Filamentation , 2006, Journal of Clinical Microbiology.

[25]  D. Sanglard,et al.  CRZ1, a target of the calcineurin pathway in Candida albicans , 2006, Molecular microbiology.

[26]  P. Perissutti,et al.  Polymicrobial Keratomycosis in a Three-Year-Old Child , 2006, Ocular immunology and inflammation.

[27]  Joseph Heitman,et al.  Calcineurin Is Required for Candida albicans To Survive Calcium Stress in Serum , 2005, Infection and Immunity.

[28]  I. F. Larrinoa,et al.  Functional characterization of the Candida albicans CRZ1 gene encoding a calcineurin-regulated transcription factor , 2005, Current Genetics.

[29]  J. Heitman,et al.  The Calcineurin Target, Crz1, Functions in Azole Tolerance but Is Not Required for Virulence of Candida albicans , 2004, Infection and Immunity.

[30]  R. Kolter,et al.  The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. , 2004, Gene.

[31]  A. Gillum,et al.  Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations , 2004, Molecular and General Genetics MGG.

[32]  J. Heitman,et al.  Disruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B in Candida lusitaniae , 2003, Antimicrobial Agents and Chemotherapy.

[33]  A. Favel,et al.  Colony morphology switching of Candida lusitaniae and acquisition of multidrug resistance during treatment of a renal infection in a newborn: case report and review of the literature. , 2003, Diagnostic microbiology and infectious disease.

[34]  Joseph Heitman,et al.  Calcineurin Is Essential for Candida albicans Survival in Serum and Virulence , 2003, Eukaryotic Cell.

[35]  Dominique Sanglard,et al.  Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence , 2003, Molecular microbiology.

[36]  L. Baddour,et al.  Candida lusitaniae infections in the era of fluconazole availability. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  Joseph Heitman,et al.  Calcineurin is essential for survival during membrane stress in Candida albicans , 2002, The EMBO journal.

[38]  J. Heitman,et al.  Calcineurin is required for hyphal elongation during mating and haploid fruiting in Cryptococcus neoformans , 2001, The EMBO journal.

[39]  I. Raad,et al.  Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  J. Heitman,et al.  A STE12 homolog is required for mating but dispensable for filamentation in candida lusitaniae. , 2000, Genetics.

[41]  G. Fink,et al.  Nonfilamentous C. albicans Mutants Are Avirulent , 1997, Cell.

[42]  J. Heitman,et al.  Calcineurin is required for virulence of Cryptococcus neoformans , 1997, The EMBO journal.

[43]  M. Pfaller,et al.  Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole , 1994, Journal of clinical microbiology.

[44]  P. Spagnuolo,et al.  Emergence of a new opportunistic pathogen, Candida lusitaniae , 1989, Journal of clinical microbiology.

[45]  Á. Durán,et al.  Effect of Calcofluor white and Congo red on fungal cell wall morphogenesis: in vivo activation of chitin polymerization , 1985, Journal of bacteriology.

[46]  W. Merz.  Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance , 1984, Journal of clinical microbiology.

[47]  J. Baker,et al.  Candida lusitaniae: a new opportunistic pathogen of the urinary tract. , 1984, Diagnostic microbiology and infectious disease.

[48]  R. Guinet,et al.  Fatal septicemia due to amphotericin B-resistant Candida lusitaniae , 1983, Journal of clinical microbiology.

[49]  R. Sentandreu,et al.  Calcofluor white alters the assembly of chitin fibrils in Saccharomyces cerevisiae and Candida albicans cells. , 1983, Journal of general microbiology.

[50]  D. Pappagianis,et al.  Development of Resistance to Amphotericin B in Candida lusitaniae Infecting a Human , 1979, Antimicrobial Agents and Chemotherapy.

[51]  D. Holzschu,et al.  Identification of Candida lusitaniae as an opportunistic yeast in humans , 1979, Journal of clinical microbiology.

[52]  Tukmachev Va,et al.  Effect of sodium dodecyl sulfate on biological membranes , 1979 .